Boundless Bio, Inc. / the approval of the respective boards of directors of the Company merger

Nothing recorded as changed on this chain yet.

• 2026-08-288-Kannouncement0001193125-26-374787

• mergerAgreementregexinferred · 50%0001193125-26-374787

  “EX-2.1 2 d111273dex21.htm EX-2.1 Exhibit 2.1 AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION This AMENDMENT NO. 1 TO AGREEMENT AND PLAN OF MERGER AND REORGANIZATION (this “ Amendment ”) is made as of August 28, 2026, with respect to that certain Agreement and Plan of Merger and Reorganization (as ame…”

• tenderOfferregexinferred · 50%0001193125-26-374787

  “o not own, directly or indirectly, at least 50% of the voting power of the surviving entity immediately after such merger or consolidation, (ii) the Company effects any sale to another Person of all or substantially all of its assets in one or a series of related transactions, (iii) pursuant to any tender offer or exch…”

• spinoffregexinferred · 50%0001193125-26-374787

  “50% of the voting power of the capital stock of the Company and the Company or such other Person, as applicable, accepts such tender for payment, (iv) the Company consummates a stock purchase agreement or other business combination (including, without limitation, a reorganization, recapitalization, spin-off or scheme o…”

• counterpartyNameregexinferred · 50%0001193125-26-374787

  “erapha Bio, Inc., a Delaware corporation (the “ Company ”). All capitalized terms used but not otherwise defined herein shall have the respective meanings ascribed to them in the Merger Agreement. W I T N E S S E T H: WHEREAS , pursuant to Section 11.2 of the Merger Agreement, the Merger Agreement may be amended by any…”

Nothing extracted yet.

Nothing extracted yet.

Subject

Boundless Bio, Inc.

Counterparty

the approval of the respective boards of directors of the Company

Minimum condition

—

Proration

Not indicated